[Federal Register Volume 89, Number 171 (Wednesday, September 4, 2024)]
[Notices]
[Pages 71908-71909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-19741]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Infant and Maternal 
Mortality

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Committee on Infant and Maternal 
Mortality (ACIMM or Committee) has scheduled a public meeting. 
Information about ACIMM and the agenda for this meeting can be found on 
the ACIMM website at https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

DATES: 
     October 16, 2024, from 9:30 a.m. to 5:15 p.m. Eastern 
Time; and
     October 17, 2024, from 9 a.m. to 1 p.m. Eastern Time.

ADDRESSES: This meeting will be held in person at the Hubert H. 
Humphrey Building, HHS Headquarters, 200 Independence Avenue SW, 
Conference Room 505A, Washington, DC 20201, and virtually via webinar. 
The webinar link and log-in information will be available at the ACIMM 
website before the meeting at https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Designated Federal 
Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane,

[[Page 71909]]

Rockville, Maryland 20857; 301-443-0543; or [email protected].

SUPPLEMENTARY INFORMATION: ACIMM is authorized by section 222 of the 
Public Health Service Act (42 U.S.C. 217a), as amended. The Committee 
is governed by provisions of the Federal Advisory Committee Act (5 
U.S.C. chapter 10), as amended.
    ACIMM advises the Secretary of HHS on department activities, 
partnerships, policies, and programs directed at reducing infant 
mortality, maternal mortality and severe maternal morbidity, and 
improving the health status of infants and women before, during, and 
after pregnancy. The Committee provides advice on how to coordinate 
federal, state, local, tribal, and territorial governmental efforts 
designed to improve infant mortality, related adverse birth outcomes, 
and maternal health, as well as influence similar efforts in the 
private and voluntary sectors. The Committee provides guidance and 
recommendations on the policies, programs, and resources required to 
address the disparities and inequities in infant mortality, related 
adverse birth outcomes and maternal health outcomes, including maternal 
mortality and severe maternal morbidity. With its focus on underlying 
causes of the disparities and inequities seen in birth outcomes for 
women and infants, the Committee advises the Secretary of HHS on the 
health, social, economic, and environmental factors contributing to the 
inequities and proposes structural, policy, and/or systems level 
changes.
    The agenda for the October 16-17, 2024, meeting is being finalized 
and may include the following topics: federal updates; presentations 
and Committee discussions on the workgroup topics of rural health care 
access, social drivers of health, and women's health before/between 
pregnancies; and discussion of possible recommendations to achieve 
optimal maternal health and overall birth outcomes for underserved 
populations, including Black/African American families. Agenda items 
are subject to change as priorities dictate. Refer to the ACIMM website 
listed above for any updated information concerning the meeting.
    Members of the public will have the opportunity to provide written 
or oral comments. Public participants may submit written statements in 
advance of the scheduled meeting by emailing [email protected]. Oral 
comments will be honored in the order they are requested and may be 
limited as time allows. Requests to submit a written statement or make 
oral comments to ACIMM should be sent to Vanessa Lee, Designated 
Federal Official, using the email address above at least 3 business 
days prior to the meeting.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify Vanessa Lee at the 
contact information listed above at least 10 business days prior to the 
meeting. Since this meeting occurs in a federal government building, 
attendees must go through a security check to enter the building. Non-
U.S. Citizen attendees must notify HRSA of their planned attendance at 
least 20 business days prior to the meeting to facilitate their entry 
into the building. All attendees are required to present government-
issued identification prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-19741 Filed 9-3-24; 8:45 am]
BILLING CODE 4165-15-P